BTA 0.00% 57.0¢ biota holdings limited

fda, glaxo warn of death due to anti-flu medic, page-8

  1. 65 Posts.
    Dank, you are right when you say that the article simply says that Relenza should be used properly.

    The problem is that GSK seems to draw the wrong conclusions and want to CANCEL IV RELENZA COMPLETELY:

    "Glaxo informed THAT THEY ARE NOT PLANNING TO RECONSTITUTE RELENZA IN ANY LIQUID FORMULATION and is not recommended for use in any nebulizer or mechanical ventilator."

    http://topnews.us/content/27645-fda-and-glaxo-issued-warning-proper-use-relenza

    I absolutely can NOT understand why GSK acts like this !

    They have made many mistakes in the marketing of Relenza before - and it seems that they will never stop...
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.